Short answer
Tenaya Therapeutics Inc (TNYA) filed an 8-K current report with the SEC on July 2, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement). Union City GMMC lease ends August 31, 2026, versus original July 2031 expiration.
Tenaya Therapeutics Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.02 · Termination of a Material Definitive Agreement
- Union City GMMC lease ends August 31, 2026, versus original July 2031 expiration
- Cost reduction from decommissioned 94,046-square-foot manufacturing facility
- Termination consideration: forfeiture of $1.75 million security deposit plus approximately $294,200 fee
- TN-201 and TN-401 trials supported by available inventory, reducing near-term manufacturing needs
- AAV manufacturing process planned for transfer to a global contract manufacturer for later-stage development or commercialization
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tenaya Therapeutics Inc 8-K filings
Get the next TNYA 8-K as it lands
Follow TNYA for push alerts, or ask the research agent what this filing means.